E 'alert in Italy for the superbug "New Delhi", resistant to almost all antibiotics known today: two cases of infection were in fact registered in our country. The news was the director of the infectious diseases department of the Higher Institute of Health (ISS), Giovanni Rezza, at the presentation of the Campaign of antibiotics, defend your defense. Use with caution. " The superbug, a native of India, has also appeared in Europe (UK, France, Sweden, The Netherlands) and the United States. E 'is resistant to most antibiotics and no new antibiotics in development is minimally effective against this organism, also known as NDM-1.
''The appearance of the superbug in Britain - said Rezza - is also partly due to a phenomenon of 'outsourcing' of surgery, for which interventions are made in India, for example, very expensive cosmetic surgery in Britain ' '. In Italy, she made known to the expert,''there has been only a couple of cases of infection in people returning from trips abroad, and there is still a real spread of the superbug, which can cause pneumonia, septicemia and infection.'' There is, however, concluded Rezza,''a state of alert and the phenomenon is constantly monitored.''
Despite the attention to this superbug must remain high, Rezza says worried by the fact that we are lowering our guard against other resistant organisms, "There are other bacteria that are resistant to the same classes of antibiotics that NDM-1 circulate in our country, now this is a serious problem especially for gram-negative bacteria, because these infections circulating in departments such as intensive care, where patients are already weakened by other serious diseases. "
The means to defend itself against these superbugs are very few: "The last bastion is the colistin (with very strong side effects, ed) - said the professor - but it does not work in cases where the problem becomes serious. There is a lack of research and development in this field, obviously the economic performance is poor compared to the investment needed, so the discovery of new drugs are lagging behind. "
With the name of NDM-1 defines a gene that can "jump" between different bacteria, giving an important resistance to carbapenems also, class of antibiotic considered the last bulwark against the microorganisms more dangerous. Throughout the Old World have been reported in 13 countries, said Dominique Monnet European Centre of Disease Prevention and Control (ECDC). "Until now - said the researcher - were reported 77 cases of NDM-1 infection in Europe -. Were affected 13 countries, including France, Italy, Germany and Spain, and there have been seven deaths. Two-thirds of cases occurred in Britain and most are associated with medical care or travel in the Indian subcontinent, although a small amount derived from an outbreak developed in the Balkans. "
Source: notizie.tiscali.it / articles / science /
0 comments:
Post a Comment